In the case of pathogenic CYP24A1 mutations, it appears logical to assume that the degree of hypercalcemia may be, as in the case of PHPT, associated with the risk of obstetric complications although we cannot definitely claim this due to relatively few reported cases. The gene discussed is CYP24A1; the disease is hypercalcemia disease.